Effect of Ki-67 Expression Levels and Histological Grade on Breast Cancer Early Relapse in Patients with Different Immunohistochemical-based Subtypes | Scientific Reports
Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype | BMC Research Notes | Full Text
Expression of ER, PR, Her2, and Ki-67 by immunohistochemical staining... | Download Scientific Diagram
The expression of ki-67 by subtypes tumor of breast cancer | Download Scientific Diagram
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score - Yang - 2023 - Cancer Medicine - Wiley Online Library
Luminal B Breast Cancer - an overview | ScienceDirect Topics
การแบ่งประเภททางโมเลกุลของมะเร็งเต้านม (Molecular classification of breast cancer) | Asian Archives of Pathology
Subtypes of Breast Cancer: Luminal B - StoryMD
Initial Treatment Decisions | Breast Surgery Specialist Melbourne, VIC
Cancers | Free Full-Text | An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients’ Age: A Retrospective Cohort Study
JPM | Free Full-Text | Correlation between Androgen Receptor Expression in Luminal B (HER–2 Negative) Breast Cancer and Disease Outcomes
Identifying the Best Ki67 Cut-Off for Determining Luminal Breast Cancer Subtypes Using Immunohistochemical Analysis and PAM50 Genomic Classification - European Medical Journal
Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study | PLOS ONE
ROC curve to determine the best Ki-67 cut-point to differentiate... | Download Scientific Diagram
![PDF] Roles of Ki67 in Breast Cancer - Important for Management? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1f578d0f9e89036c6d0cc2b70ae78f5df8660b2c/3-Table1-1.png "PDF] Roles of Ki67 in Breast Cancer - Important for Management? | Semantic Scholar")
PDF] Roles of Ki67 in Breast Cancer - Important for Management? | Semantic Scholar
Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors
MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation - Modern Pathology
Breast Cancer Subtypes And Prognosis: Answers To Subgroup Classification Questions, Identifying The Worst Subgroup In Our Single-Center Series - Article (Preprint v1) by Rusen Cosar et al. | Qeios
PinPointcases - INACTIVE --- Adjuvant systemic treatment of luminal A/B early breast cancer
Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information | Modern Pathology
Performance of Ki67 (as a continuous variable) to predict Luminal A or... | Download Scientific Diagram
Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index - ScienceDirect
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes | springermedizin.de
![PDF] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/60a5e17db2ebec70ad7ebb9addd7b2a5f3bf9992/6-Figure1-1.png "PDF] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer | Semantic Scholar")
PDF] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer | Semantic Scholar
